agilon health inc. (AGL)
agilon health inc. Statistics
Share Statistics
agilon health inc. has 412.3M shares outstanding. The number of shares has increased by 0.6% in one year.
Shares Outstanding | 412.3M |
Shares Change (YoY) | 0.6% |
Shares Change (QoQ) | 0.13% |
Owned by Institutions (%) | 99.99% |
Shares Floating | 303.5M |
Failed to Deliver (FTD) Shares | 18.08K |
FTD / Avg. Volume | 0.35% |
Short Selling Information
The latest short interest is 25.25M, so 6.13% of the outstanding shares have been sold short.
Short Interest | 25.25M |
Short % of Shares Out | 6.13% |
Short % of Float | 8.33% |
Short Ratio (days to cover) | 6.65 |
Valuation Ratios
The PE ratio is -3 and the forward PE ratio is -44.95. agilon health inc.'s PEG ratio is 1.92.
PE Ratio | -3 |
Forward PE | -44.95 |
PS Ratio | 0.13 |
Forward PS | 0.2 |
PB Ratio | 1.66 |
P/FCF Ratio | -10.99 |
PEG Ratio | 1.92 |
Enterprise Valuation
agilon health inc. has an Enterprise Value (EV) of 5.07B.
EV / Earnings | -19.49 |
EV / Sales | 0.84 |
EV / EBITDA | -23.24 |
EV / EBIT | -17.35 |
EV / FCF | -71.38 |
Financial Position
The company has a current ratio of 1.27, with a Debt / Equity ratio of 0.09.
Current Ratio | 1.27 |
Quick Ratio | 1.27 |
Debt / Equity | 0.09 |
Total Debt / Capitalization | 8.1 |
Cash Flow / Debt | -1.39 |
Interest Coverage | -47.29 |
Financial Efficiency
Return on equity (ROE) is -0.55% and return on capital (ROIC) is -57.34%.
Return on Equity (ROE) | -0.55% |
Return on Assets (ROA) | -0.15% |
Return on Capital (ROIC) | -57.34% |
Revenue Per Employee | $5,632,462.83 |
Profits Per Employee | $-241,729.55 |
Employee Count | 1,076 |
Asset Turnover | 3.5 |
Inventory Turnover | n/a |
Taxes
Income Tax | 1.45M |
Effective Tax Rate | -0.01 |
Stock Price Statistics
The stock price has increased by -32.93% in the last 52 weeks. The beta is 0.68, so agilon health inc.'s price volatility has been higher than the market average.
Beta | 0.68 |
52-Week Price Change | -32.93% |
50-Day Moving Average | 3.12 |
200-Day Moving Average | 4.01 |
Relative Strength Index (RSI) | 64.03 |
Average Volume (20 Days) | 5.15M |
Income Statement
In the last 12 months, agilon health inc. had revenue of 6.06B and earned -260.1M in profits. Earnings per share was -0.63.
Revenue | 6.06B |
Gross Profit | 4.84M |
Operating Income | -292.13M |
Net Income | -260.1M |
EBITDA | -218.19M |
EBIT | -292.13M |
Earnings Per Share (EPS) | -0.63 |
Balance Sheet
The company has 188.23M in cash and 41.5M in debt, giving a net cash position of 146.73M.
Cash & Cash Equivalents | 188.23M |
Total Debt | 41.5M |
Net Cash | 146.73M |
Retained Earnings | -1.59B |
Total Assets | 1.73B |
Working Capital | 305.77M |
Cash Flow
In the last 12 months, operating cash flow was -57.78M and capital expenditures -13.25M, giving a free cash flow of -71.03M.
Operating Cash Flow | -57.78M |
Capital Expenditures | -13.25M |
Free Cash Flow | -71.03M |
FCF Per Share | -0.17 |
Margins
Gross margin is 0.08%, with operating and profit margins of -4.82% and -4.29%.
Gross Margin | 0.08% |
Operating Margin | -4.82% |
Pretax Margin | -4.11% |
Profit Margin | -4.29% |
EBITDA Margin | -3.6% |
EBIT Margin | -4.82% |
FCF Margin | -1.17% |
Dividends & Yields
AGL does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Payout Ratio | n/a |
Earnings Yield | -16.28% |
FCF Yield | -4.45% |
Analyst Forecast
The average price target for AGL is $3, which is -22.5% lower than the current price. The consensus rating is "Hold".
Price Target | $3 |
Price Target Difference | -22.5% |
Analyst Consensus | Hold |
Analyst Count | 17 |
Scores
Altman Z-Score | 2.58 |
Piotroski F-Score | 3 |